Inactive

The AlloSeq Tx (ASTX17.1 (96) -A-RUO kits allow the interrogation of HLA genotyping (Human Leucocyte Antigen genotyping) on Next-Generation Sequencing platform for The CDC Office of Science (OS), Offi... The AlloSeq Tx (ASTX17.1 (96) -A-RUO kits allow the interrogation of HLA genotyping (Human Leucocyte Antigen genotyping) on Next-Generation Sequencing platform for The CDC Office of Science (OS), Office of Genomics and Precision Public Health (OGPPH) CDC Funding Integrating Human Genomics into Applied Research and Public Health Surveillance awarded project “Enhancing hemophilia inhibitor risk prediction using genetic risk prediction models in a diverse patient population funding,” The next-generation in genetic matching is provided with the AlloSeq Tx kit utilizing an unique hybrid capture technology. This technology is only available and compatible with the existing Illumina MiSeq platform in our laboratory. AlloSeq Tx leverages Nextera Flex for Enrichment hybrid capture technology from Illumina Inc. to enrich the genes of interest from a whole genome library preparation. The use of hybrid capture technology, as opposed to traditional long-range PCR techniques enables the flexibility of variable gene-sequence content without the need for workflow changes. No other company manufactures or sells this product